Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
IBA (Ion Beam Applications S.A.) is a pioneering global medical technology company dedicated to developing innovative solutions for cancer diagnosis and treatment. As the world leader in proton therapy technology, IBA provides cutting-edge systems for radiation therapy. The company also offers solutions for radiopharmacy, dosimetry, and particle accelerators for medical and industrial applications, striving to improve patient outcomes and advance healthcare worldwide.
Global corporate management, research and development, manufacturing of key components for proton therapy and accelerator systems, and central administrative services.
State-of-the-art facilities for particle accelerator development and assembly, advanced research laboratories, and a modern campus designed to foster innovation.
A highly innovative and collaborative environment, focused on scientific excellence, patient impact, and continuous improvement. Emphasis on teamwork, precision, and a commitment to advancing cancer care.
Serves as the nerve center for IBA's global operations, R&D leadership, and strategic decision-making. Its location in a prominent European technology hub fosters collaboration with academic and research institutions.
IBA supports its global customer base through a network of offices and service centers across North America, Europe, and Asia. This widespread presence enables local sales, project management, installation, maintenance services, and customer training for its proton therapy, radiopharma, and dosimetry solutions, ensuring responsive and comprehensive support worldwide.
Chemin du Cyclotron 3
Louvain-la-Neuve
Walloon Brabant
Belgium
Address: 44425 Pecan Square, Sterling, VA 20166, USA
To serve and expand IBA's presence in the key North American healthcare market, providing localized support, training, and expertise.
Address: IBA Particle Therapy (Beijing) Co., Ltd., Room 1101, Building A, Gemdale Plaza, No.91 Jianguo Road, Chaoyang District, Beijing 100022, P.R. China
To support the growing demand for advanced cancer treatment technologies in China and the broader Asian market, adapting solutions to local needs.
Address: IBA Dosimetry GmbH, Bahnhofstraße 5, 64291 Darmstadt, Germany
To lead innovation and provide high-quality dosimetry products and services globally, with a strong presence in Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, IBA' leadership includes:
IBA has been backed by several prominent investors over the years, including:
IBA has actively strengthened its leadership team over the past 12-18 months, with key appointments in pivotal roles such as Chief Medical Officer for RadioTherapy and Chief People Officer, aimed at driving strategic growth and operational excellence.
Discover the tools IBA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
IBA typically uses a standard professional email format for its employees, generally combining the employee's first and last name, or initial and last name, with the company's primary domain. The most common format observed is [firstinitial][lastname]@iba-worldwide.com or [first].[last]@iba-worldwide.com.
[firstinitial][lastname]@iba-worldwide.com (e.g., jdoe@iba-worldwide.com) or [first].[last]@iba-worldwide.com (e.g., john.doe@iba-worldwide.com)
Format
jdoe@iba-worldwide.com
Example
85%
Success rate
IBA Press Release • May 8, 2024
IBA announced a new contract with ParticleTech for the installation of its compact single-room proton therapy solution, Proteus®ONE, at a new Danish particle therapy center. This marks an expansion of advanced cancer care in Denmark....more
IBA Press Release • April 25, 2024
IBA appointed Dr. Juergen Kusch as its new Chief Medical Officer for RadioTherapy. This strategic hire aims to strengthen IBA's medical leadership and drive innovation in its radiotherapy solutions....more
IBA Press Release • March 14, 2024
IBA announced its financial results for the full year 2023, showcasing significant growth in proton therapy sales, increased overall profitability, and a positive outlook for future expansion in cancer treatment solutions and radiopharma....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including IBA, are just a search away.